FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087251033> ?p ?o ?g. }

• W3087251033 endingPage "3694" @default.
• W3087251033 startingPage "3683" @default.
• W3087251033 abstract "Hyperthyroidism is associated with low levels of cholesterol and triglycerides, and hypothyroidism is associated with hypercholesterolemia and hypertriglyceridemia.The aim of this systematic review was to investigate the impact of therapy for overt and subclinical hyper- and hypothyroidism on serum lipids.We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and Scopus from 1970 through April 5, 2018.Pairs of independent reviewers selected randomized and observational studies evaluating lipid parameters in patients undergoing treatment for hyper- or hypothyroidism.Pairs of independent reviewers extracted data and appraised studies.Treatment of overt hyperthyroidism showed a significant increase in total cholesterol (TC) by 44.50 mg/dL (95% confidence interval [CI]: 37.99, 51.02), low-density lipoprotein cholesterol (LDL-C) by 31.13 mg/dL (95% CI: 24.33, 37.93), high-density lipoprotein cholesterol (HDL-C) by 5.52 mg/dL (95% CI: 1.48, 9.56), apolipoprotein A (Apo A) by 15.6 mg/dL (95% CI: 10.38, 20.81), apolipoprotein B (apo B) by 26.12 mg/dL (95% CI: 22.67, 29.57), and lipoprotein (Lp[a]) by 4.18 mg/dL (95% CI: 1.65, 6.71). There was no significant change in triglyceride (TG) levels. Treatment of subclinical hyperthyroidism did not change any lipid parameters significantly. Levothyroxine therapy in overt hypothyroidism showed a statistically significant decrease in TC by -58.4 mg/dL (95% CI: -64.70, -52.09), LDL-C by -41.11 mg/dL (95% CI: -46.53, -35.69), HDL-C by -4.14 mg/dL (95% CI: -5.67, -2.61), TGs by -7.25 mg/dL (95% CI: -36.63, 17.87), apo A by -12.59 mg/dL (95% CI: -17.98, -7.19), apo B by -33.96 mg/dL (95% CI: 41.14, -26.77), and Lp(a) by -5.6 mg/dL (95% CI: -9.06, -2.14). Levothyroxine therapy in subclinical hypothyroidism showed similar changes but with a smaller magnitude. The studies contained varied population characteristics, severity of thyroid dysfunction, and follow-up duration.Treatment of overt but not subclinical hyperthyroidism is associated with worsening of the lipid profile. Levothyroxine therapy in both overt and subclinical hypothyroidism leads to improvement in the lipid profile, with a smaller magnitude of improvement in subclinical hypothyroidism." @default.
• W3087251033 created "2020-09-25" @default.
• W3087251033 creator A5005709414 @default.
• W3087251033 creator A5009474972 @default.
• W3087251033 creator A5015511114 @default.
• W3087251033 creator A5036768419 @default.
• W3087251033 creator A5044371501 @default.
• W3087251033 creator A5054802858 @default.
• W3087251033 creator A5073495332 @default.
• W3087251033 creator A5074738537 @default.
• W3087251033 creator A5086101167 @default.
• W3087251033 date "2020-09-21" @default.
• W3087251033 modified "2023-10-13" @default.
• W3087251033 title "Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis" @default.
• W3087251033 cites W1598602811 @default.
• W3087251033 cites W1827222256 @default.
• W3087251033 cites W1967312649 @default.
• W3087251033 cites W1982111232 @default.
• W3087251033 cites W2009355303 @default.
• W3087251033 cites W2060962757 @default.
• W3087251033 cites W2065423518 @default.
• W3087251033 cites W2066308251 @default.
• W3087251033 cites W2068309857 @default.
• W3087251033 cites W2074513248 @default.
• W3087251033 cites W2077977355 @default.
• W3087251033 cites W2088199680 @default.
• W3087251033 cites W2090982939 @default.
• W3087251033 cites W2097159742 @default.
• W3087251033 cites W2104355263 @default.
• W3087251033 cites W2107328434 @default.
• W3087251033 cites W2118780561 @default.
• W3087251033 cites W2125435699 @default.
• W3087251033 cites W2126930838 @default.
• W3087251033 cites W2143987962 @default.
• W3087251033 cites W2144962038 @default.
• W3087251033 cites W2151722413 @default.
• W3087251033 cites W2156098321 @default.
• W3087251033 cites W2158920974 @default.
• W3087251033 cites W2160009803 @default.
• W3087251033 cites W2163957464 @default.
• W3087251033 cites W2164576143 @default.
• W3087251033 cites W2168146687 @default.
• W3087251033 cites W2168406714 @default.
• W3087251033 cites W2510464317 @default.
• W3087251033 cites W2515067460 @default.
• W3087251033 cites W2522904710 @default.
• W3087251033 cites W2530107877 @default.
• W3087251033 cites W2592797625 @default.
• W3087251033 cites W2598836722 @default.
• W3087251033 cites W2751481664 @default.
• W3087251033 cites W2800239085 @default.
• W3087251033 cites W2811575556 @default.
• W3087251033 cites W2887724139 @default.
• W3087251033 cites W2894730508 @default.
• W3087251033 cites W2945825315 @default.
• W3087251033 cites W2991792334 @default.
• W3087251033 cites W4296883165 @default.
• W3087251033 doi "https://doi.org/10.1210/clinem/dgaa672" @default.
• W3087251033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32954428" @default.
• W3087251033 hasPublicationYear "2020" @default.
• W3087251033 type Work @default.
• W3087251033 sameAs 3087251033 @default.
• W3087251033 citedByCount "43" @default.
• W3087251033 countsByYear W30872510332021 @default.
• W3087251033 countsByYear W30872510332022 @default.
• W3087251033 countsByYear W30872510332023 @default.
• W3087251033 crossrefType "journal-article" @default.
• W3087251033 hasAuthorship W3087251033A5005709414 @default.
• W3087251033 hasAuthorship W3087251033A5009474972 @default.
• W3087251033 hasAuthorship W3087251033A5015511114 @default.
• W3087251033 hasAuthorship W3087251033A5036768419 @default.
• W3087251033 hasAuthorship W3087251033A5044371501 @default.
• W3087251033 hasAuthorship W3087251033A5054802858 @default.
• W3087251033 hasAuthorship W3087251033A5073495332 @default.
• W3087251033 hasAuthorship W3087251033A5074738537 @default.
• W3087251033 hasAuthorship W3087251033A5086101167 @default.
• W3087251033 hasBestOaLocation W30872510331 @default.
• W3087251033 hasConcept C126322002 @default.
• W3087251033 hasConcept C134018914 @default.
• W3087251033 hasConcept C2775883008 @default.
• W3087251033 hasConcept C2776919658 @default.
• W3087251033 hasConcept C2778163477 @default.
• W3087251033 hasConcept C2778913445 @default.
• W3087251033 hasConcept C44249647 @default.
• W3087251033 hasConcept C526584372 @default.
• W3087251033 hasConcept C62746215 @default.
• W3087251033 hasConcept C71924100 @default.
• W3087251033 hasConcept C90924648 @default.
• W3087251033 hasConcept C95190672 @default.
• W3087251033 hasConceptScore W3087251033C126322002 @default.
• W3087251033 hasConceptScore W3087251033C134018914 @default.
• W3087251033 hasConceptScore W3087251033C2775883008 @default.
• W3087251033 hasConceptScore W3087251033C2776919658 @default.
• W3087251033 hasConceptScore W3087251033C2778163477 @default.
• W3087251033 hasConceptScore W3087251033C2778913445 @default.
• W3087251033 hasConceptScore W3087251033C44249647 @default.
• W3087251033 hasConceptScore W3087251033C526584372 @default.
• W3087251033 hasConceptScore W3087251033C62746215 @default.

• next